secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORTHOPEDIATRICS CORP (KIDS)
CIK:        0001425450
Form:       8-K
Filed at:   2022-10-31T23:59:59+00:00
Accession:  0001425450-22-000101
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OrthoPediatrics Q3 revenue up 39% to $35M; cuts FY2022 revenue guidance to $124-125M
--------------------------------------------------------------------------------

- Revenue $35.0M (+39% YoY); organic growth ~22% excluding MD Ortho and Pega Medical contributions of $4.4M.
- Net income $18.5M ($0.87 diluted EPS) vs net loss ($2.2M) in Q3 2021, includes $23M fair value adjustment.
- FY2022 revenue guidance lowered to $124-125M (from $127-130M); organic guidance $113-114M (15-16% growth).
- Adjusted EBITDA $1.9M vs $0.5M in Q3 2021; cash and equivalents $121.6M with no debt drawn.
- Company cites RSV infections and staffing shortages as September headwinds; Pega Medical acquisition closed in July.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425450/000142545022000101/0001425450-22-000101-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425450/000142545022000101/kids-20221031.htm
  HTML page:      https://secwatch.observer/filing/0001425450-22-000101

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer